Table 2.
Clinicopathologic characteristics of patients in the ARH and R-CT groups.
| Characteristic | Before propensity score matching | After propensity score matching | ||||
|---|---|---|---|---|---|---|
| ARH group (n=658) | R-CT group (n=66) | P value | ARH group (n=126) | R-CT group (n=64) | P value | |
| Age | 52.13 ± 9.74 | 58.11 ± 8.54 | <0.001 | 57.67 ± 8.35 | 57.67 ± 8.30 | 0.997 |
| Tumor size | 2.97 ± 0.89 | 3.16 ± 0.98 | 0.094 | 3.04 ± 0.81 | 3.19 ± 0.97 | 0.249 |
| Histological type | 0.320 | 0.619 | ||||
| Squamous cell carcinoma | 605 (91.9%) | 64 (97%) | 118 (93.7%) | 62 (96.9%) | ||
| Adenocarcinoma | 36 (5.5%) | 1(1.5%) | 5 (4%) | 1 (1.6%) | ||
| Adenosquamous carcinoma | 17 (2.6%) | 1 (1.5%) | 3 (2.4%) | 1 (1.6%) | ||
ARH, abdominal radical hysterectomy; R-CT, radio-chemotherapy; OS, overall survival; DFS, disease-free survival.